Comparative efficacy and tolerability of 32 oral and long-acting injectable antipsychotics for the maintenance treatment of adults with schizophrenia: a systematic review and network meta-analysis.

耐受性 医学 荟萃分析 分裂情感障碍 精神科 精神分裂症(面向对象编程) 随机对照试验 抗精神病药 内科学 安慰剂
作者
A Cipriani
出处
期刊:The Lancet [Elsevier BV]
卷期号:399 (10327): 824-836 被引量:2
标识
DOI:10.1016/s0140-6736(21)01997-8
摘要

Schizophrenia is a common, severe, and usually chronic disorder. Maintenance treatment with antipsychotic drugs can prevent relapse but also causes side-effects. We aimed to compare the efficacy and tolerability of antipsychotics as maintenance treatment for non-treatment resistant patients with schizophrenia.In this systematic review and network meta-analysis, we searched, without language restrictions, the Cochrane Schizophrenia Group's specialised register between database inception and April 27, 2020, PubMed from April 1, 2020, to Jan 15, 2021, and the lists of included studies from related systematic reviews. We included randomised controlled trials (RCTs; ≥12 weeks of follow-up) that recruited adult participants with schizophrenia or schizoaffective disorder with stable symptoms who were treated with antipsychotics (monotherapy; oral or long-acting injectable) or placebo. We excluded RCTs of participants with specific comorbidities or treatment resistance. In duplicate, two authors independently selected eligible RCTs and extracted aggregate data. The primary outcome was the number of participants who relapsed and was analysed by random-effects, Bayesian network meta-analyses. The study was registered on PROSPERO, CRD42016049022.We identified 4157 references through our search, from which 501 references on 127 RCTs of 32 antipsychotics (comprising 18 152 participants) were included. 100 studies including 16 812 participants and 30 antipsychotics contributed to our network meta-analysis of the primary outcome. All antipsychotics had risk ratios (RRs) less than 1·00 when compared with placebo for relapse prevention and almost all had 95% credible intervals (CrIs) excluding no effect. RRs ranged from 0·20 (95% CrI 0·05-0·41) for paliperidone oral to 0·65 (0·16-1·14) for cariprazine oral (moderate-to-low confidence in estimates). Generally, we interpret that there was no clear evidence for the superiority of specific antipsychotics in terms of relapse prevention because most comparisons between antipsychotics included a probability of no difference.As we found no clear differences between antipsychotics for relapse prevention, we conclude that the choice of antipsychotic for maintenance treatment should be guided mainly by their tolerability.The German Ministry of Education and Research and Oxford Health Biomedical Research Centre.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
王多肉完成签到,获得积分10
刚刚
Iiiilr完成签到 ,获得积分10
1秒前
杨幂完成签到,获得积分10
2秒前
9秒前
hellokitty完成签到,获得积分10
12秒前
12秒前
小四发布了新的文献求助10
13秒前
19秒前
西瓜完成签到 ,获得积分10
19秒前
包容的忆灵完成签到 ,获得积分10
22秒前
高兴尔冬发布了新的文献求助10
24秒前
xiang完成签到 ,获得积分0
27秒前
小四完成签到,获得积分10
30秒前
FashionBoy应助slayers采纳,获得30
36秒前
量子星尘发布了新的文献求助10
39秒前
黑眼圈完成签到 ,获得积分10
45秒前
jia完成签到 ,获得积分10
46秒前
如履平川完成签到 ,获得积分10
47秒前
科目三应助忧伤的步美采纳,获得10
48秒前
大椒完成签到 ,获得积分10
51秒前
54秒前
56秒前
wisdom完成签到,获得积分10
56秒前
slayers发布了新的文献求助30
59秒前
1分钟前
e746700020完成签到,获得积分10
1分钟前
高兴尔冬完成签到,获得积分10
1分钟前
李爱国应助不安的秋白采纳,获得10
1分钟前
忧伤的步美完成签到,获得积分10
1分钟前
小西完成签到 ,获得积分10
1分钟前
郝老头完成签到,获得积分10
1分钟前
13313完成签到,获得积分10
1分钟前
su完成签到 ,获得积分10
1分钟前
1分钟前
1分钟前
量子星尘发布了新的文献求助10
1分钟前
slayers完成签到 ,获得积分10
1分钟前
1分钟前
知犯何逆完成签到,获得积分10
1分钟前
Krsky完成签到,获得积分10
1分钟前
高分求助中
【提示信息,请勿应助】关于scihub 10000
Les Mantodea de Guyane: Insecta, Polyneoptera [The Mantids of French Guiana] 3000
徐淮辽南地区新元古代叠层石及生物地层 3000
The Mother of All Tableaux: Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 3000
Handbook of Industrial Diamonds.Vol2 1100
Global Eyelash Assessment scale (GEA) 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 550
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 4038039
求助须知:如何正确求助?哪些是违规求助? 3575756
关于积分的说明 11373782
捐赠科研通 3305574
什么是DOI,文献DOI怎么找? 1819239
邀请新用户注册赠送积分活动 892655
科研通“疑难数据库(出版商)”最低求助积分说明 815022